| 영문 | injection | 한글 | 주입 |
|---|---|---|---|
| 설명 | 액체를 피하조직, 혈관, 또는 장기 등 어떤 부분에 밀어 넣는 것, 또는 그러한 방법으로 투여된 물질을 말한다. |
||
| 영문 | heparin | 한글 | 헤파린 |
|---|---|---|---|
| 설명 | 혈액 응고를 막는 작용을 하는 다당류의 황산에스테르. 고등동물의 각종 조직에 널리 분포되어 있으며, 수술 후의 혈전증을 막는 데 쓴다. 혈액응고란 지혈의 한 과정으로 섬유소란 물질을 만들어 내는 과정이다. 이 섬유소는 손상된 혈관의 부위에 작용하여 여러 가지 세포들을 얽어 묶는 역할을 하여 결국 손상된 혈관에서 혈액의 소실을 막는다. 이 섬유소는 트롬빈에 의해 섬유소원에서 전환된다. 헤파린이라는 물질은 이 트롬빈을 억제하는 항트롬빈을 활성화하는 물질이다. |
||
| SI | International System of Units [Fr. le Systeme International d'Unites]; sacroiliac; saline infusion; ... |
|---|---|
| SI | System of International Units (Systeme International D'unites) |
| GUA | group of units of analysis |
| ICRU | International Commission on Radiation Units and Measurements |
| IU/l | international units per liter |
| CPAF | Chlorpropamide-alcohol flush |
|---|---|
| LMW heparin | Low Molecular Weight heparin |
| EIS | Endoscopic Injection Sclerotherapy |
| FIA | Flow Injection Analysis |
| FI | Flow injection |
| carcinoid flush | Periodic hyperaemia (flushing) of the skin of the face and other parts of the body seen in patients with a carcinoid tumour; the mediator has not been identified but it is not serotonin; flush can be precipitated by alcohol, food, stress, or palpation of the liver. (05 Mar 2000) |
|---|---|
| malar flush | Localised hectic flush and warmth of the malar eminences, often occurring in tuberculosis and sometimes seen in rheumatic fever. (05 Mar 2000) |
| hectic flush | Redness of the face associated with a rise of temperature in various fevers. (05 Mar 2000) |
| histamine flush | Vasodilatation and erythema occurring as a result of release of histamine; thought to be a factor in genesis of flush of carcinoid syndrome. (05 Mar 2000) |
| hot flush | <symptom> A sensation of heat and flushing that occurs suddenly. May be associated with menopause or some medications. (09 Oct 1997) |
| flush | <clinical sign> Transient, episodic redness of the face and neck caused by certain diseases, ingestion of certain drugs or other substances, heat, emotional factors or physical exertion. (18 Nov 1997) |
| flush end | <molecular biology> The ends of a blunt-end DNA molecule, where both strands in the double-stranded DNA molecule are even with each other rather than one strand being longer than the other. (09 Oct 1997) |
| flush technique | <procedure> A technique for determining the systolic blood pressure in infants; the elevated limb is milked of blood from the hand or foot proximally; the blood pressure cuff is then inflated above the likely systolic pressure and the limb lowered; the cuff pressure is then gradually released until the blanched limb flushes. (05 Mar 2000) |
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|